about
A comprehensive review on metabolic syndromeIschemic heart disease in women: a focus on risk factorsProtective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidityMetabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcomeAdipocytokines and obesity-linked disordersMetabolic syndrome, inflammation and atherosclerosisHeme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stressPotent PPARĪ± activator derived from tomato juice, 13-oxo-9,11-octadecadienoic acid, decreases plasma and hepatic triglyceride in obese diabetic miceThe metabolic syndrome and mind-body therapies: a systematic review.The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: a systematic review.Caloric restriction stimulates revascularization in response to ischemia via adiponectin-mediated activation of endothelial nitric-oxide synthaseMetabolic syndrome in rheumatoid arthritis: case control studyFactors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico.Fetal programming of adipose tissue: effects of intrauterine growth restriction and maternal obesity/high-fat diet.Adiponectin-mediated modulation of hypertrophic signals in the heartAmorpha fruticosa - A Noxious Invasive Alien Plant in Europe or a Medicinal Plant against Metabolic Disease?Metabolic syndrome and its predictors in an urban population in Kenya: A cross sectional study.An animal model of spontaneous metabolic syndrome: Nile grass ratAdipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI studyLong-term obesity promotes alterations in diastolic function induced by reduction of phospholamban phosphorylation at serine-16 without affecting calcium handling.Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study.Systemic inflammation and the metabolic syndrome among middle-aged community volunteers.Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.Factor structure underlying components of allostatic loadIncreased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study.Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.Metabolomic analysis of akt1-mediated muscle hypertrophy in models of diet-induced obesity and age-related fat accumulation.Relationship between Metabolic Syndrome and MTHFR Polymorphism in Colorectal Cancer.Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease.Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentThe risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies.Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS andNonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-L-thyronine in rats.Pathophysiology of dyslipidaemia in the metabolic syndrome.HIV is an independent predictor of aortic stiffness.High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors.Central obesity: association with left ventricular dysfunction and mortality in the community.High Prevalence of Diabetic Retinopathy in Diabetic Patients Concomitant with Metabolic Syndrome.Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals?Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein B on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention
P2860
Q21284500-DFC008A3-DC94-4A40-AD5B-4DE26CEDDE23Q22251459-54778D3F-F496-4F2C-BBAC-78AF647F473DQ24630655-FA5B9CD2-73D0-4B3B-B120-2F507380AE02Q26799612-2CB824A2-5C77-4A92-9888-15FED1FC5B65Q27021977-76F6E1EB-4B40-416E-A997-BFFBA093056FQ28219348-BDD793DE-C8F2-4ADE-B955-0D22CAD06368Q28541319-09CEFD20-FE4D-4249-8C75-58BED133878CQ28732165-ABEC44EB-31AF-49D2-BF04-16B87B037501Q30405042-23DA9649-8643-4950-AE94-A94EBF661325Q30443817-53DCB275-8EC1-4734-AD27-5A26265F5D4AQ30850845-C9381AF5-1993-4BFE-BF89-03A93BFDD145Q31116097-042C9AA9-4A15-4D5A-B3A3-5986D1A605FCQ33379277-B6E240AC-C5EB-4F4B-88F0-95E15C918798Q33567132-24D8254D-8B52-4314-B370-416ABDC742F8Q33688678-B1ED6D85-8B1D-4C63-BE74-B4E1010B94A5Q33774694-3644D5B8-1AA1-4845-95E4-17771AD67B96Q33869151-C0F44AA5-AA04-442B-B09C-472A1E300E89Q33919499-43764415-5CE4-4F55-9F88-1A20E7CE4CF2Q33926100-CD264561-9526-4526-B252-DCF230EBB777Q34146928-177BA397-60A8-4CFA-9948-038CD3EA967EQ34147834-C06BB8B1-F642-4A29-9657-5AD803FCDD43Q34200504-243EDD38-41DC-477D-918F-998331C61481Q34332478-B4473D58-B046-4CD1-97AA-6968247563DBQ34462148-DD50F646-EC33-4BE1-9A1F-CE92F9CBE6A2Q34614038-4B90A9B7-4522-4136-9475-D7BBEE2EC71CQ34620441-1A8515A2-81F2-4F65-9F53-70CDC8B5DFA5Q34855354-2B1F5EB2-0F6F-4DDE-BC3A-A1838FA0F319Q34971242-A63B3783-C273-4EDD-BAA8-C7411A0311E6Q35018429-DA06A97D-3915-41B5-AA6C-ECA2D655A500Q35029623-D4FB7CEE-1676-4F11-B9C9-C427607903AEQ35036116-1F0C717B-3A4B-4D10-B76C-62CAB7C1AD6AQ35185494-D7B5DAC9-880E-492B-9AB3-CF9363133F7FQ35405379-F62A1CB4-0F09-4DD4-A345-55A20258A8D2Q35522107-1B031382-12B5-418A-B203-9107965F6730Q35576175-28CCDD6F-0CB4-4102-956F-6973BB27B7A6Q35638692-E6A066BD-1A9A-4115-BB55-EBC356D43A0CQ35750487-58481FFB-50F3-49AF-9ACA-2052961EB9A2Q35888609-062D78DC-3A3C-4744-A311-39D29D0286B0Q35905936-03B5F070-8FD0-4BD2-B6A0-9E30DEC870FEQ36015920-BCFD37E8-B452-4659-BF39-4F63DC72ABB8
P2860
description
2003 nĆ® lÅ«n-bĆ»n
@nan
2003 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕ„ÕŗÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2003 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ½Õ„ÕŗÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2003幓ć®č«ę
@ja
2003幓č«ę
@yue
2003幓č«ę
@zh-hant
2003幓č«ę
@zh-hk
2003幓č«ę
@zh-mo
2003幓č«ę
@zh-tw
2003幓č®ŗę
@wuu
name
The metabolic syndrome: more than the sum of its parts?
@ast
The metabolic syndrome: more than the sum of its parts?
@en
type
label
The metabolic syndrome: more than the sum of its parts?
@ast
The metabolic syndrome: more than the sum of its parts?
@en
prefLabel
The metabolic syndrome: more than the sum of its parts?
@ast
The metabolic syndrome: more than the sum of its parts?
@en
P1433
P1476
The metabolic syndrome: more than the sum of its parts?
@en
P2093
Daniel J Rader
P304
P356
10.1161/01.CIR.0000088846.10655.E0
P407
P577
2003-09-01T00:00:00Z